KLR Business Group, Inc., dba Arkansas Clinical Research

Little Rock, Arkansas 72205

0 studies enrolling now · 6 studies all time

What they study most

COVID-19, Cardiovascular Diseases, Chronic Kidney Disease, Chronic Pain, Migraine, With or Without Aura, Obesity, Osteoarthritis, Hip, Osteoarthritis, Knee, Overweight, Overweight or Obesity, Type 2 Diabetes

Studies at this site

• A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk — Completed
• A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity — Running, not enrolling
• A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight — Completed
• A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness — Completed
• Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee — Completed
• Efficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of Migraine — Completed